Neurofibromatosis Program

  • Meet the Team

    The Neurofibromatosis Program is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.

  • Show All

    Medical Director

    A photo of Maryam Fouladi.

    Maryam Fouladi, MD, MSc, FRCPC
    Medical Director, Neuro-Oncology Program

    513-636-4266

    maryam.fouladi@cchmc.org

    Maryam Fouladi, MD, MSc, FRCPC

    Medical Director, Neuro-Oncology Program

    Chair, Pediatric Brain Tumor Consortium Steering Committee

    Cincinnati Children's Principal Investigator, Collaborative Ependymoma Research Network

    Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: maryam.fouladi@cchmc.org

    Show All

    Biography

    Maryam Fouladi, MD, MSc, graduated from the University of Toronto School of Medicine, and completed her pediatric residency and hematology / oncology fellowship training at the Hospital for Sick Children in Toronto, Canada. Dr. Fouladi then completed her neuro-oncology fellowship training at St. Jude Children's Research Hospital, and later completed further training in the molecular pharmacology department at St. Jude before becoming a  neuro-oncology faculty member in 2000. She served as the chair of the Phase I Committee at St. Jude.

    Dr. Fouladi moved to Cincinnati Children's in 2008 to direct the neuro-oncology program. She is currently chair for the CNS Tumor New Agent Committee for the Children’s Oncology Group. She is a member of the steering committee for the COG CNS Tumor Committee as well as the Developmental Therapeutics group at COG, and is a member of the Collaborative Ependymoma Research Network (CERN). She serves as local and national study chair (through CERN, COG and the Pediatric Brain Tumor Consortium) for clinical trials that test new approaches to treat children with very poor prognosis tumors such as high-grade gliomas and diffuse intrinsic pontine gliomas.

    Education and Training

    BS: Human Biology, University of Toronto, Toronto, Canada, 1987. 

    MD: University of Toronto, Toronto, Canada, 1991.

    MSc: Institute of Medical Science, University of Toronto, Toronto, Canada, 2002.

    Publications

    View PubMed Publications

    Oncology

    A photo of Maryam Fouladi.

    Maryam Fouladi, MD, MSc, FRCPC
    Medical Director, Neuro-Oncology Program

    513-636-4266

    maryam.fouladi@cchmc.org

    Maryam Fouladi, MD, MSc, FRCPC

    Medical Director, Neuro-Oncology Program

    Chair, Pediatric Brain Tumor Consortium Steering Committee

    Cincinnati Children's Principal Investigator, Collaborative Ependymoma Research Network

    Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: maryam.fouladi@cchmc.org

    Show All

    Biography

    Maryam Fouladi, MD, MSc, graduated from the University of Toronto School of Medicine, and completed her pediatric residency and hematology / oncology fellowship training at the Hospital for Sick Children in Toronto, Canada. Dr. Fouladi then completed her neuro-oncology fellowship training at St. Jude Children's Research Hospital, and later completed further training in the molecular pharmacology department at St. Jude before becoming a  neuro-oncology faculty member in 2000. She served as the chair of the Phase I Committee at St. Jude.

    Dr. Fouladi moved to Cincinnati Children's in 2008 to direct the neuro-oncology program. She is currently chair for the CNS Tumor New Agent Committee for the Children’s Oncology Group. She is a member of the steering committee for the COG CNS Tumor Committee as well as the Developmental Therapeutics group at COG, and is a member of the Collaborative Ependymoma Research Network (CERN). She serves as local and national study chair (through CERN, COG and the Pediatric Brain Tumor Consortium) for clinical trials that test new approaches to treat children with very poor prognosis tumors such as high-grade gliomas and diffuse intrinsic pontine gliomas.

    Education and Training

    BS: Human Biology, University of Toronto, Toronto, Canada, 1987. 

    MD: University of Toronto, Toronto, Canada, 1991.

    MSc: Institute of Medical Science, University of Toronto, Toronto, Canada, 2002.

    Publications

    View PubMed Publications

    Trent R. Hummel, MD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-1126

    Fax: 513-636-3549

    Email: trent.hummel@cchmc.org

    Show All

    Specialties

    Neuro-oncology; CNS tumors in neurofibromatosis type 1 and 2 research interests: developing novel therapeutics in central nervous system tumors including those with very poor prognosis such as high grade gliomas and diffuse intrinsic pontine gliomas.

    Biography

    Trent R. Hummel, MD, completed his graduate medical training at the University of Cincinnati College of Medicine, residency training in pediatrics at Children's Hospital Medical Center of Akron and pediatric hematology/oncology training at Cincinnati Children's Hospital Medical Center. His current appointment is with the University of Cincinnati and Children's Hospital Medical Center in the capacity of assistant professor of pediatrics.

    Dr. Hummel's clinical and academic interests pertain to children and families affected by central nervous system tumors. He is a member of the Central Nervous System (Brain Tumor) Committee in the Children's Oncology Group (COG) as well as the Cincinnati Children's co-principal investigator for the Pediatric Brain Tumor Consortium (PBTC). Dr. Hummel focuses on developing novel therapeutics to treat children with all central nervous system tumors including those patients with neurofibromatosis type 1 and 2 related CNS tumors and very poor prognosis tumors such as high-grade gliomas and diffuse intrinsic pontine gliomas.

    Education and Training

    BS: Eastern Mennonite University, 1997. 

    MD: University of Cincinnati College of Medicine, 2001.

    Residency: Children’s Hospital Medical Center of Akron, Akron, Ohio, 2004.

    Fellowship: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, 2007; Research Fellow, Division of Experimental Hematology, Cincinnati Children’s Hospital Medical Center, 2008.

    Certification: American Board of Pediatrics, 2004; Pediatrics, 2004. Pediatric Hematology / Oncology, 2011.

    Publications

    View PubMed Publications

    A photo of Brian Weiss.

    Brian D. Weiss, MD
    Associate Director for Safety and Compliance, Cancer and Blood Diseases Institute

    513-636-9863

    brian.weiss@cchmc.org

    Brian D. Weiss, MD

    Associate Director for Safety and Compliance, Cancer and Blood Diseases Institute

    Associate Director of Clinical Research, Division of Oncology

    Cincinnati Children's Principal Investigator, New Approaches to Neuroblastoma Therapy Consortium

    Medical Director, Neuroblastoma Program

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-9863

    Fax: 513-636-3549

    Email: brian.weiss@cchmc.org

    Show All

    Specialties

    Targeted agents for neurofibromatosis type 1-related malignancies; high-risk neuroblastoma and 131I-MIBG treatment of neuroblastoma; new approaches to targeting and killing neuroblastoma cells

    Education and Training

    MD: Northwestern University Medical School, Chicago, IL, 1993.

    Residency and Chief Residency: Pediatrics, University of California, San Francisco, CA, 1993-1997.

    Fellowship: Pediatric Hematology/Oncology, University of California, San Francisco, CA, 1997-2000.

    Certification: National Medical Board; Pediatrics;1996, 2002; Pediatric Hematology-Oncology, 2000, 2007

    Publications

    View PubMed Publications

    Grants

    Children's Oncology Group Chairs Grant. National Institutes of Health (Children's Oncology Group)
    U10 CA 098543 Mar 2011 - Feb 2012.

    Genetics

    A photo of Robert J. Hopkin.

    Robert J. Hopkin, MD
    Co-Director, 22Q-VCFS Center

    513-636-4760

    rob.hopkin@cchmc.org

    Robert J. Hopkin, MD

    Co-Director, 22Q-VCFS Center

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4760

    Fax: 513-636-7297

    Email: rob.hopkin@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Fabry disease and other lysosomal storage diseases; craniofacial genetics; 22q11 deletion; clinical intervention for genetic disease; neurofibromatosis; dysmorphology; prenatal diagnosis of genetic syndromes

    Research Interests

    Fabry disease; Robin sequence; 22q11 deletion; neurofibromatosis; craniofacial genetics; chromosomal anomalies

    Biography

    Robert J. Hopkin, MD, is an associate professor of clinical pediatrics at Cincinnati Children's Hospital Medical Center. Dr. Hopkin graduated from the University of Nevada Medical School. He completed residency and chief residency in pediatrics at the Phoenix Children's Hospital, Maricopa Medical Center Combined Residency Program. His training in medical genetics was completed at Cincinnati Children's Hospital Medical Center.

    The majority of Dr. Hopkin's time is spent in caring for patients with genetic disorders. He participates in clinics from Fetal Care to Adult Genetics. He is also actively involved in education of health care providers regarding the application of genetics for patient care. Dr Hopkin has participated in a number of clinical trials and is a member of American College of Medical Genetics Committee on Therapeutics. He has participated in natural history studies on Fabry disease, Pompe disease, velocardiofacial syndrome, Pierre Robin sequence, Neurofibromatosis type I, and several other genetic conditions. The unifying principle in his research interests is application of scientific knowledge to improve outcomes for patients afflicted with genetic disorders.

    Education and Training

    MD: University of Nevada Medical School, Reno, NV, 1990.

    Residency: Phoenix Children's Hospital, Manicopa Medical Center, Phoenix, AZ, 1993; Phoenix Children's Hospital, Manicopa Medical Center, Phoenix, AZ, 1994.

    Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1997.

    Certification: Pediatrics, 1993; Clinical Genetics, 1996.

    Publications

    View PubMed Publications
    A photo of Howard Saal.

    Howard M. Saal, MD, FACMG
    Director, Clinical Genetics

    513-636-2438

    howard.saal@cchmc.org

    Howard M. Saal, MD, FACMG

    Director, Clinical Genetics

    Director, Cytogenetics Laboratory

    Co-Director, 22Q-VCFS Center

    Professor, UC Department of Pediatrics

    Phone: 513-636-2438

    Fax: 513-636-7297

    Email: howard.saal@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Craniofacial disorders, community genetics, growth disorders, 22Q-VCFS

    Research Interests

    Genetic etiologies and natural histories of craniofacial disorders and new syndrome delineation

    Biography

    Howard M. Saal, MD, a highly respected clinical geneticist and dysmorphologist, is the head of the section of Clinical Genetics in the Division of Human Genetics at Cincinnati Children's Hospital Medical Center. In addition to being board certified in clinical genetics and pediatrics, Dr. Saal is a board certified cytogeneticist.

    Early in his career, he was the Director of the Cytogenetics Laboratory at the University of Connecticut Health Center, where he was also the associate director of the Craniofacial Disorders Team.

    Dr. Saal is interested in the genetic causes of craniofacial disorders, especially cleft lip and cleft palate. He also has a significant interest in the natural history of genetic conditions, and has authored or co-authored numerous publications centering on the natural history and management of various genetic conditions, with special attention to neurofibromatosis, cleft lip, cleft palate, Pierre Robin sequence and 22Q-VCFS.

    After leaving Connecticut, Dr. Saal went to Children's National Medical Center in Washington, DC, where he was the Vice-Chairman of the Department of Medical Genetics and co-director of the Craniofacial Center. His clinical activities included establishment of the Neurofibromatosis Clinic, the Biochemical Genetics Clinic, and the multidisciplinary Skeletal Dysplasia Clinic with his colleagues at Children's National Medical Center. His interest in community activities led to his being named to the Health Professionals Advisory Committee and later to the Board of Directors of the National Capital Area March of Dimes.

    Dr. Saal joined the staff at Cincinnati Children's in 1993 as the Head of Clinical Genetics. He has been an active participant in numerous clinical settings and has established the Hereditary Cancer Program, a unique local resource for families with familial and inherited cancers.

    Dr. Saal is involved in community activities and has established urban genetics outreach clinics at three sites in Hamilton County. He has also been appointed as acting director of the Craniofacial Center at Cincinnati Children's, where he continues to cultivate his interests in the care of children with craniofacial disorders.

    Education and Training

    MD: Wayne State University, Detroit, MI, 1975-1979.

    Internship: University of Connecticut Integrated Program in Pediatrics, Farmington, CT, 1979-1980.

    Residency: University of Connecticut Integrated Program in Pediatrics, Farmington, CT, 1980-1982.

    Fellowship: University of Washington School of Medicine Division of Medical Genetics, Seattle, WA, 1982-1984.

    Certification: American Board of Medical Genetics in Cytogenetics and Clinical Genetics, 1984; American Board of Pediatrics, 1985.

    Publications

    View PubMed Publications

    A photo of Elizabeth Schorry.

    Elizabeth K. Schorry, MD
    Director, Neurofibromatosis Clinic

    513-636-0121

    elizabeth.schorry@cchmc.org

    Elizabeth K. Schorry, MD

    Director, Neurofibromatosis Clinic

    Director, Adult Neurofibromatosis Clinic

    Professor, UC Department of Pediatrics

    Phone: 513-636-0121

    Fax: 513-636-7297

    Email: elizabeth.schorry@cchmc.org

    Show All

    Specialties


    Biography

    Elizabeth Schorry, MD, received her undergraduate degree at the University of Cincinnati and her MD at the University of Michigan in Ann Arbor, Michigan.

    Dr. Schorry completed a residency in pediatrics and a fellowship in medical genetics at Cincinnati Children's Hospital Medical Center. She has been a faculty member in the Division of Human Genetics at Cincinnati Children's since 1988.

    Dr. Schorry provides medical management, genetic assessment and genetic counseling for children with a wide range of genetic disorders and congenital anomalies. She has a special interest in neurofibromatosis and tuberous sclerosis.

    Education and Training

    BS: Biology, University of Cincinnati, Cincinnati, OH, 1977.

    MD: University of Michigan, Ann Arbor, MI, 1982.

    Residency: Pediatrics, Children's Hospital Medical Center, Cincinnati, OH, 1982-1985.

    Fellowship: Genetics, Children's Hospital Medical Center, Cincinnati, OH, 1985-1988.

    Certification: American Board of Pediatrics, 1987; Clinical Genetics, American Board of Medical Genetics, 1987.

    Publications

    View PubMed Publications

    Neurology

    A photo of Mary Sutton.

    Mary Sutton, MD

    513-636-4222

    Mary Sutton, MD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4222

    Fax: 513-636-3980

    Show All

    Specialties

    Neuro-oncology

    Education and Training

    MD: University of Rochester School of Medicine and Dentistry, Rochester, NY, 1989.

    Residency: Pediatrics, Children's Hospital, Boston, MA.

    Fellowship: Neurology, Children's Hospital, Boston, MA.

    Certification: Pediatrics, 1996; Neurology, 1996.

    Researchers

    A photo of Lionel Chow.

    Lionel M. L. Chow, MD, PhD
    Member, Cancer Biology and Neural Tumors Program

    513-803-1369

    lionel.chow@cchmc.org

    Lionel M.L. Chow, MD, PhD

    Member, Cancer Biology and Neural Tumors Program

    St. Baldrick’s Foundation Scholar

    Sontag Foundation Distinguished Scientist

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-1369

    Fax: 513-636-3549

    Email: lionel.chow@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Pediatric neuro-oncology

    Research Interests

    Mouse models for glioma; molecular profiling of tumor mutations; biomarkers of tumor progression; novel therapeutic agents for glioma

    Visit the Chow Lab

    Biography

    Lionel Chow, MD, PhD, received his medical and graduate degrees from McGill University in Montreal, Canada, where his research focused on the regulation of T-lymphocyte signaling by the intracellular tyrosine protein kinases Lck and Csk.

    Following his clinical training in pediatrics and pediatric hematology / oncology at the Hospital for Sick Children in Toronto, Canada, he moved to St. Jude Children’s Research Hospital in Memphis, Tenn., to pursue his research interests.

    Chow's research interests have been centered on glioblastoma multiforme, a particularly devastating form of cancer in adults and children. His work has resulted in the development of a number of novel and robust laboratory models for this disease. Using these models and interfacing with clinical trials in the Neuro-Oncology Program as well as those from national consortia such as the Children's Oncology Group (COG) and the Pediatric Brain Tumor Consortium (PBTC), Chow’s laboratory will continue research in this area with the goals of better understanding the origins of this form of cancer and improving patient outcomes.

    Education and Training

    PhD: McGill University, Montreal, Quebec, Canada, 1996.

    MDCM: McGill University, Montreal, Quebec, Canada, 1997.

    Residency: The Hospital for Sick Children, University of Toronto, Toronto, Canada, 1997-2000.

    Clinical Fellowship: The Hospital for Sick Children, University of Toronto, Toronto, Canada, 2000-2003.

    Postdoctoral Fellowship: St. Jude Children’s Research Hospital, Memphis, TN, 2003-2009.

    Clinical Fellowship: St. Jude Children’s Research Hospital, Memphis TN, 2008-2009.

    Certification: Pediatrics, 2000.

    Publications

    View PubMed Publications

    Grants

    2013 – 2014 Sophie’s Angel Run Foundation
    “Preclinical Testing of Notch and mTor Inhibition in a Mouse Model for High-Grade Glioma” 

    2011 – 2014 St. Baldrick’s Foundation Scholars Award
    "Molecular targeting of pediatric high-grade glioma"

    2011 – 2015 Sontag Foundation Distinguished Scientist Award
    "Molecular targeting of high-grade astrocytoma"

    A photo of Dr. Biplab Dasgupta.

    Biplab Dasgupta, PhD, MS
    Member, Cancer Biology and Neural Tumors Program

    513-803-1370

    biplab.dasgupta@cchmc.org

    Biplab Dasgupta, PhD, MS

    Member, Cancer Biology and Neural Tumors Program

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-1370

    Fax: 513-803-1083

    Email: biplab.dasgupta@cchmc.org

    Show All

    Specialties

    Biography

    Biplab Dasgupta, PhD, MS, completed his doctorate in molecular biology and immunology at the Indian Institute of Chemical Biology, Calcutta, and a postdoctoral fellowship at Washington University School of Medicine, Saint Louis. Dr. Dasgupta came to Cincinnati Children's Hospital Medical Center in August 2009 as an assistant professor of pediatrics. He is interested in understanding how neural cell / stem cell metabolic and energy status is linked to cell cycle, lineage commitment, differentiation and tumorigenesis. His other interests include genetic, developmental, post-translational, tissue- and stimuli–specific regulation of the subunits that constitute the AMP kinase complex.

    Education and Training

    PhD: Indian Institute of Chemical Biology, Calcutta, 2003

    Postdoctoral Fellowship:
    Washington University School of Medicine, Saint Louis

    Publications

    View PubMed Publications

    Grants

    Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase. Principal Investigator. National Institute of Neurological Disorders and Stroke (NINDS). July 2012 – June 2017.

    A photo of Nancy Ratner.

    Nancy Ratner, PhD
    Beatrice C. Lampkin Chair, Cancer Biology

    513-636-9469

    nancy.ratner@cchmc.org

    Nancy Ratner, PhD

    Beatrice C. Lampkin Chair, Cancer Biology

    Program Leader, Cancer and Biology and Neural Tumors Program

    Professor, UC Department of Pediatrics

    Phone: 513-636-9469

    Fax: 513-636-3549

    Email: nancy.ratner@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Development of the nervous system; peripheral nerve tumor formation

    Research Interests

    Genetic mutations in tumor suppressor genes

    Visit the Ratner Lab.

    Biography

    Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in Neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR as a potential therapeutic target in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST. 

    Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004. Dr. Ratner is currently a professor in the Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, and the program leader for Cancer Biology and Neural Tumors Program in the Cancer and Blood Diseases Institute where she holds the Beatrice C. Lampkin Endowed chair in cancer biology and serves as PI of the NINDS P50 “Cincinnati Center in NF Research”. 

    Dr. Ratner is an active member of the International Consortium on the Molecular Biology of NF1, NF2, and schwannomatosis and was a member of the advisory board for the National Neurofibromatosis Foundation (now Children’s Tumor Foundation) from 1989 to 2007. She chaired the Department of Defense Neurofibromatosis Research Program Integration Panel in 2008, and currently serves as a member of the James McDonnell Brain Tumor Research Advisory Board. She received the von Recklinghausen Award from the Children’s Tumor Foundation in 2010.

    Education and Training

    PhD: Indiana University, 1982.

    BA: Brown University, 1975.

    Fellowship: Washington University St. Louis, 1982-1987.

    Publications

    View PubMed Publications

    Grants

    Mitogenic Activities in Neurofibromatosis. Principle Investigator. Sept 2011-2016. NIH-R01 NS 28840-20.
    A photo of Sander Vinks.

    Alexander A. Vinks, PharmD, PhD, FCP
    Director, Division of Clinical Pharmacology

    513-636-0159

    sander.vinks@cchmc.org

    Sander A. Vinks, PharmD, PhD, FCP

    Director, Division of Clinical Pharmacology

    Professor, UC Department of Pediatrics

    Adjunct Professor of Pharmacology

    Phone: 513-636-0159

    Fax: 513-636-0168

    Email: sander.vinks@cchmc.org

    Show All

    Biography

    Dr. Vinks received his MS in pharmacology from the University of Toronto, Canada and a pharmacy degree and PhD in pharmacology from Leiden University, The Netherlands. He was trained as a hospital pharmacist (PharmD) and clinical pharmacologist at The Hague Hospitals Central Pharmacy, The Hague, The Netherlands.

    Before joining the Division of Pharmacology Research at Cincinnati Children's Hospital Medical Center, he was director of the Clinical Pharmacology & Toxicology Laboratory at The Hague. Dr. Vinks has spent over 20 years in the field of therapeutic drug monitoring and applied pharmacokinetics, both in the research aspects of population pharmacokinetic studies, as well as in the clinical application of these approaches to clinical patient care.

    Dr. Vinks holds an academic appointment with the University of Cincinnati College of Medicine and is the principal investigator for the Pediatric Pharmacology Research Unit (PPRU). He is director of the Laboratory of Applied Pharmacokinetics and Therapeutic Drug Management (LAP/TDM) and clinical pharmacology fellowship program at Cincinnati Children's. His current research interests include pharmacokinetic-pharmacodynamic (PK-PD) modeling and the application of population and simulation methods in TDM and clinical trial design. He has authored over 50 publications in the area of TDM, pharmacokinetics and clinical pharmacology. Dr. Vinks has been actively involved with International Association of Therapeutic Drug Monitoring and Clinical Toxicology from the beginning. He is chair of the TDM cost-effectiveness committee, serves as secretary of the Executive Board of Directors, and is on the editorial board of the journal Therapeutic Drug Monitoring. Dr. Vinks is both board certified in clinical pharmacology and toxicology and is a fellow of the American College of Clinical Pharmacology.

    Education and Training

    Certification American Board of Clinical Pharmacology, 2001.

    PhD Clinical Pharmacology, Leiden University, Leiden The Netherlands, 1996.

    PharmD Hospital Pharmacy, The Hague Central Hospital Pharmacy, The Hague, The Netherlands, 1986 .

    MS Pharmacology, University of Toronto, Toronto Canada, 1983.

    MS Pharmacy, Leiden University, Leiden, The Netherlands, 1982.

    Publications

    View PubMed Publications

    A photo of Jianqiang Wu.

    Jianqiang Wu, MD, MS
    Member, Cancer Biology and Neural Tumors Program

    513-636-0955

    jianqiang.wu@cchmc.org

    Jianqiang Wu, MD, MS

    Member, Cancer Biology and Neural Tumors Program

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-0955

    Fax: 513-803-0783

    Email: jianqiang.wu@cchmc.org

    Show All

    Specialties

    Preclinical therapeutic trial on neurofibroma; cancer stem cell(s) in neurofibroma

    Education and Training

    MD: Soochow University College of Medicine, SooChow, P.R. China, 1991.

    MS: Soochow University College of Medicine, SooChow, P.R. China, 1996.

    Publications

    View PubMed Publications